SCHEMBL17437382

SCHEMBL17437382

Nc1ncnn1-c1nc2cncc(-c3ccc(Cl)cc3Cl)c2n1-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ DPP4 P27487 2/20 0.33
▸ EGLN2 Q96KS0 1/20 0.33
▸ MARS1 P56192 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAT2A P31153 1/20 0.32
▸ OPRM1 P35372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437482 0.90 MEN1 (0.33) USP2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL17437568 0.84 DPP4 (0.37) HSP90AB1DPP4EGLN2LMNA
SCHEMBL17437313 0.83 MAPT (0.34) USP2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL17437523 0.81 DPP4 (0.39) CYP1A2CYP3A4CYP2C9CYP2C19HSP90AB1
SCHEMBL17437394 0.80 CYP1A2 (0.33) CYP1A2CYP3A4DPP4EGLN2LMNA
SCHEMBL17437381 0.80 CRHR1 (0.35) MEN1KMT2ALMNA
SCHEMBL17437549 0.80 DPP4 (0.36) DPP4LMNAKDM4E
SCHEMBL17437328 0.78 CYP1A2 (0.35) USP2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL17437310 0.75 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C19TSHRHIF1A
SCHEMBL17437317 0.75 ALDH1A1 (0.33) USP2CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 USP2 4400/4885CYP1A2 25/4885CYP3A4 59/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 USP2 4400/4885CYP1A2 25/4885CYP3A4 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback